Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 224

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment

Szajewska, H., Horvath, A., Piwowarczyk, A. · 2010 · Alimentary Pharmacology & Therapeutics

Abstract

Aliment Pharmacol Ther 2010; 32: 1069–1079 Summary: Background Problems with currently recommended Helicobacter pylori eradication therapies include unsatisfactory eradication rates and/or therapy‐associated side effects. Aim To investigate the effects of Saccharomyces boulardii as supplementation to standard triple therapy on H. pylori eradication rates and therapy‐associated side effects. Methods The Cochrane Library, MEDLINE and EMBASE databases were searched in July 2010, with no language restrictions, for randomized controlled trials (RCTs); additional references were obtained from reviewed articles. Results Five RCTs involving a total of 1307 participants (among them only 90 children) met the inclusion criteria. Compared with placebo or no intervention, S. boulardii given along with triple therapy significantly increased the eradication rate [four RCTs, n = 915, relative risk (RR) 1.13, 95% confidence interval (CI) 1.05–1.21] and reduced the risk of overall H. pylori therapy‐related adverse effects (five RCTs, n = 1305, RR 0.46, 95% CI 0.3–0.7), particularly of diarrhoea (four RCTs, n = 1215, RR 0.47, 95% CI 0.32–0.69). There were no significant differences between groups in the risk of other adverse effects. Conclusion In patients with H. pylori infection, there is evidence to recommend the use of S. boulardii along with standard triple therapy as an option for increasing the eradication rates and decreasing overall therapy‐related side effects, particularly diarrhoea.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2010.04457.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 224

Metadata

Authors
Szajewska, H., Horvath, A., & Piwowarczyk, A.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2010-09-16
Volume
32
Issue
9
Pages
1069-1079
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1846719679
Cited by
224
References
6
FWCI
16.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. https://app.cochat.ai/papers/10.1111/j.1365-2036.2010.04457.x
The paper
Szajewska, H., Horvath, A., & Piwowarczyk, A. (2010). Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2010.04457.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.